Keyphrases
Cancer Treatment
100%
Cancer Risk
100%
Risk Treatment
100%
Hereditary Leiomyomatosis
100%
Renal Cancer
100%
Cancer Surveillance
100%
Risk-based Surveillance
100%
Fumarate Hydratase
27%
Early Onset
18%
International Symposium
9%
Clinical Trials
9%
Screening Method
9%
Cancer-related
9%
Large Cohort
9%
Management Protocol
9%
Susceptible Individuals
9%
Consensus Conference
9%
Systemic Treatment
9%
Mutation Carriers
9%
Autosomal Dominant
9%
Surgical Excision
9%
Renal Tumor
9%
Germline mutation
9%
Renal Imaging
9%
Predictive Testing
9%
Metastatic Disease
9%
Cutaneous Leiomyoma
9%
Cancer Families
9%
Abdominal MRI
9%
Papillary Renal Cell Cancer
9%
Retroperitoneal Lymph Node Dissection (RPLND)
9%
Leiomyoma Uteri
9%
Surgical Considerations
9%
Wide Margin
9%
Tricarboxylic Acid (Krebs) Cycle
9%
Medicine and Dentistry
Cancer Treatment
100%
Cancer Cell
100%
Cancer Risk
100%
Leiomyomatosis
100%
Kidney Cancer
100%
Fumarate Hydratase
30%
Metastatic Carcinoma
10%
Clinical Trial
10%
Screening
10%
Magnetic Resonance Imaging
10%
Lifespan
10%
Systemic Therapy
10%
Surgical Margin
10%
Kidney Tumour
10%
Citric Acid Cycle
10%
Germline Mutation
10%
Autosomal Dominant Inheritance
10%
Uterine Fibroid
10%
Angioleiomyoma
10%
Predictive Testing
10%
Tricarboxylic Acid
10%
Retroperitoneal Lymph Node Dissection
10%